معرفی
Yonit Lavin is an Instructor at the Charles Rudin Lab within the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. Her research focuses on immunological mechanisms in cancer, particularly investigating tumor microenvironment dynamics, immune checkpoint therapies, and cellular plasticity in malignancies like mesothelioma and hepatocellular carcinoma. She employs advanced techniques such as single-cell profiling and genomic analyses to understand how immune responses influence cancer progression and treatment efficacy.
Her work spans multiple cancer types, including lung, ovarian, and gastrointestinal cancers, with an emphasis on translational research linking basic immunology to clinical outcomes. Key themes include identifying biomarkers predictive of immunotherapy response, dissecting the roles of dendritic cells and T cell subsets in tumor immunity, and elucidating cytokine networks influencing disease severity in conditions like COVID-19.
Lavin’s publications highlight contributions to understanding microRNA regulatory networks in immune cells, the role of CSF-1 in microglial function, and the molecular underpinnings of tumor immune evasion. Her research bridges fundamental biology with clinical applications, aiming to improve therapeutic strategies targeting cancer’s immune microenvironment.
